Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 410

1.

Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients.

Riley M, Bakeberg M, Byrnes M, Jefferson A, Ghosh S, Stell R, Mastaglia FL, Hince D, Anderton RS.

Parkinsons Dis. 2018 Apr 19;2018:9472120. doi: 10.1155/2018/9472120. eCollection 2018.

2.

Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.

Fabis-Pedrini MJ, James I, Seewann A, Yau WY, van de Bovenkamp AA, Sanders FRK, Qiu W, Burton J, Mastaglia FL, Carroll WM, Kermode AG.

J Neurol Sci. 2018 May 15;388:12-18. doi: 10.1016/j.jns.2018.02.036. Epub 2018 Feb 22.

PMID:
29627005
3.

Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.

Gutteridge DH, Mastaglia FL.

Intern Med J. 2017 Oct;47(10):1199-1201. doi: 10.1111/imj.13567.

PMID:
28994265
4.

Extended "Timed Up and Go" assessment as a clinical indicator of cognitive state in Parkinson's disease.

Evans T, Jefferson A, Byrnes M, Walters S, Ghosh S, Mastaglia FL, Power B, Anderton RS.

J Neurol Sci. 2017 Apr 15;375:86-91. doi: 10.1016/j.jns.2017.01.050. Epub 2017 Jan 17.

PMID:
28320196
5.

Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.

Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd TE, Lundberg IE, Mastaglia F, Mozaffar T, Needham M, Schmidt J, Sivakumar K, DeMuro C, Tseng BS.

J Neuromuscul Dis. 2016 Mar 3;3(1):67-75.

6.

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.

Gang Q, Bettencourt C, Machado PM, Brady S, Holton JL, Pittman AM, Hughes D, Healy E, Parton M, Hilton-Jones D, Shieh PB, Needham M, Liang C, Zanoteli E, de Camargo LV, De Paepe B, De Bleecker J, Shaibani A, Ripolone M, Violano R, Moggio M, Barohn RJ, Dimachkie MM, Mora M, Mantegazza R, Zanotti S, Singleton AB, Hanna MG, Houlden H; Muscle Study Group and The International IBM Genetics Consortium.

Neurobiol Aging. 2016 Nov;47:218.e1-218.e9. doi: 10.1016/j.neurobiolaging.2016.07.024. Epub 2016 Aug 8.

7.

Diagnostic performance of a commercial immunoblot assay for myositis antibody testing.

Bundell C, Rojana-Udomsart A, Mastaglia F, Hollingsworth P, McLean-Tooke A.

Pathology. 2016 Jun;48(4):363-6. doi: 10.1016/j.pathol.2016.03.012. Epub 2016 Apr 22.

PMID:
27114370
8.

Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women.

Bates KA, Sohrabi HR, Rainey-Smith SR, Weinborn M, Bucks RS, Rodrigues M, Beilby J, Howard M, Taddei K, Martins G, Paton A, Shah T, Dhaliwal SS, Foster JK, Martins IJ, Lautenschlager NT, Mastaglia FL, Gandy SE, Martins RN.

Int J Neurosci. 2017 Mar;127(3):243-252. doi: 10.1080/00207454.2016.1182527. Epub 2016 May 15.

PMID:
27113638
9.

Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment.

Needham M, Mastaglia FL.

Clin Neurophysiol. 2016 Mar;127(3):1764-73. doi: 10.1016/j.clinph.2015.12.011. Epub 2015 Dec 19. Review.

PMID:
26778717
10.

Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Needham M, Mastaglia FL.

Neurotherapeutics. 2016 Jan;13(1):132-46. doi: 10.1007/s13311-015-0394-2. Review.

11.

Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.

van der Stap DK, Rider LG, Alexanderson H, Huber AM, Gualano B, Gordon P, van der Net J, Mathiesen P, Johnson LG, Ernste FC, Feldman BM, Houghton KM, Singh-Grewal D, Kutzbach AG, Alemo Munters L, Takken T; International Myositis Assessment and Clinical Studies Group.

J Rheumatol. 2016 Jan;43(1):169-76. doi: 10.3899/jrheum.150270. Epub 2015 Nov 15. Review.

12.

Advances and challenges in developing a therapy for spinal muscular atrophy.

Anderton RS, Mastaglia FL.

Expert Rev Neurother. 2015;15(8):895-908. doi: 10.1586/14737175.2015.1059757. Review.

PMID:
26200127
13.

SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.

Huang Y, Wang G, Rowe D, Wang Y, Kwok JB, Xiao Q, Mastaglia F, Liu J, Chen SD, Halliday G.

Biomed Res Int. 2015;2015:135674. doi: 10.1155/2015/135674. Epub 2015 Apr 15.

14.

Interactive effects of GPI stimulation and levodopa on postural control in Parkinson's disease.

Johnson L, Rodrigues J, Teo WP, Walters S, Stell R, Thickbroom G, Mastaglia F.

Gait Posture. 2015 May;41(4):929-34. doi: 10.1016/j.gaitpost.2015.03.346. Epub 2015 Apr 3.

PMID:
25861706
15.

Evidence for an excitatory GABAA response in human motor cortex in idiopathic generalised epilepsy.

Silbert BI, Heaton AE, Cash RF, James I, Dunne JW, Lawn ND, Silbert PL, Mastaglia FL, Thickbroom GW.

Seizure. 2015 Mar;26:36-42. doi: 10.1016/j.seizure.2015.01.014. Epub 2015 Jan 29.

16.

Bone mineral density, adiposity, and cognitive functions.

Sohrabi HR, Bates KA, Weinborn M, Bucks RS, Rainey-Smith SR, Rodrigues MA, Bird SM, Brown BM, Beilby J, Howard M, Criddle A, Wraith M, Taddei K, Martins G, Paton A, Shah T, Dhaliwal SS, Mehta PD, Foster JK, Martins IJ, Lautenschlager NT, Mastaglia F, Laws SM, Martins RN.

Front Aging Neurosci. 2015 Feb 18;7:16. doi: 10.3389/fnagi.2015.00016. eCollection 2015.

17.

205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands.

De Bleecker JL, De Paepe B, Aronica E, de Visser M; ENMC Myositis Muscle Biopsy Study Group, Amato A, Aronica E, Benveniste O, De Bleecker J, de Boer O, De Paepe B, de Visser M, Dimachkie M, Gherardi R, Goebel HH, Hilton-Jones D, Holton J, Lundberg IE, Mammen A, Mastaglia F, Nishino I, Rushing E, Schroder HD, Selcen D, Stenzel W.

Neuromuscul Disord. 2015 Mar;25(3):268-72. doi: 10.1016/j.nmd.2014.12.001. Epub 2014 Dec 10. No abstract available.

PMID:
25572016
18.

Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.

Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S.

Muscle Nerve. 2015 Aug;52(2):196-203. doi: 10.1002/mus.24541. Epub 2015 Jan 6.

PMID:
25521389
19.

Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches.

Mastaglia FL, Needham M.

J Clin Neurosci. 2015 Jan;22(1):6-13. doi: 10.1016/j.jocn.2014.09.012. Epub 2014 Dec 12. Review.

PMID:
25510538
20.

Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis.

RodrĂ­guez Cruz PM, Needham M, Hollingsworth P, Mastaglia FL, Hillman DR.

Neuromuscul Disord. 2014 Dec;24(12):1036-41. doi: 10.1016/j.nmd.2014.08.003. Epub 2014 Aug 20.

PMID:
25227894

Supplemental Content

Loading ...
Support Center